IHH Annual Report 2019

Investment facilitated for digitalising healthcare and precision medicine capabilities, improving care and service quality standards Access to international laboratory diagnostics capability through SRL Diagnostics, cost savings and improved diagnostic efficiency Effective clinical governance across the Group through the International Clinical Governance Advisory Council (ICGAC) Singapore 4 hospitals 50+ clinics Greater China 2 hospitals 8 medical centres SCALE WITH EXCELLENCE Adopting a multi-country portfolio strategy, IHH diversifies our earnings base in cashflow-generative markets. We are also scaling up our presence in Greater China with new services in Gleneagles Hong Kong and the opening of Gleneagles Chengdu in October 2019 with 30 beds in its initial phase. Strong ecosystem of 77 hospitals in 10 markets Scale Read more on Business Strategy on pages 44 and 45 7